Iovance Biotherapeutics
Iovance Biotherapeutics is a late-stage oncology company with the potential to bring the first novel autologous T cell therapy to the market for solid tumors in patients with significant unmet needs.
$123.0m
Money raised
Overview
Iovance Biotherapeutics is a late-stage oncology company with the potential to bring the first novel autologous T cell therapy to the market for solid tumors in patients with significant unmet needs.
-
Website:
- Business model: B2B
- Headquarters: San Carlos, California
- Social accounts:
| Name | Phone | Social networks | |
|---|---|---|---|
| Ma**** Si*** | - | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Me Mc**** | - | - | - |
| At**** Co* | - | - | |
| Ry** Ma | - | - | - |
| Mi We**** | - | - | - |
Industries
Iovance Biotherapeutics is active in the following industries: